SK Chemicals Reports Q1 2026 Consolidated Operating Loss of KRW 18.9 Billion; Life Science Segment Continues Losses

Consolidated Q1 2026 revenue: KRW 655.9 billion, operating loss: KRW 18.9 billion, net loss attributable to parent: KRW 12.1 billion (swung to loss vs prior year).
Green Chemicals Biz. posted operating profit of KRW 15.9 billion, but Life Science Biz. recorded an operating loss of KRW 39.1 billion.
Approximately 10 lawsuits related to humidifier disinfectant (e.g., indemnity claims) are ongoing, with total claim amount of about KRW 117.4 billion.
Derivative liabilities: exchangeable bonds KRW 53.3 billion, currency forward contracts etc. KRW 0.69 billion.
Consolidated R&D expenditure: KRW 12.0 billion (1.8% of revenue).
Total assets: KRW 6.11 trillion, total liabilities: KRW 2.98 trillion, equity: KRW 3.13 trillion.